Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 1 / 2 Trials for Cyclosporine (DB00091)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01650545Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant RecipientsTreatment